ERBB3 and breast neoplasm: To further evaluate the tumor-homing capacity of HPK nucleocapsids in vivo, we assessed delivery in mice bearing two different human breast tumors with high and low/no HER3 expression (JIMT1 and 231, respectively) (Figure 6F).